Immunopathologia Persa
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.9 | Q4 | 5.5% | 0.232 | Q4 | 33.8% |
| 2024 | 0.7 | Q4 | 3.8% | 0.187 | Q4 | 28.1% |
| 2023 | 1.1 | Q4 | 10.2% | 0.232 | Q4 | 40.2% |
| 2022 | 0.8 | 6.3% | 0.189 | Q4 | 35.6% | |
| 2021 | — | 14.6% | 0.168 | Q4 | 33.7% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF